Home

Petros Moustardas

Principal Research Engineer

Publications

2023

Maria Xeroudaki, Mehrdad Rafat, Petros Moustardas, Anthonny Mukwaya, Shideh Tabe, Marco Bellisario, Beatrice Peebo, Neil Lagali (2023) A double-crosslinked nanocellulose-reinforced dexamethasone-loaded collagen hydrogel for corneal application and sustained anti-inflammatory activity Acta Biomaterialia, Vol. 172, p. 234-248 Continue to DOI
Petros Moustardas, Daniel Aberdam, Neil Lagali (2023) MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges Cells, Vol. 12, Article 617 Continue to DOI
Mojdeh Abbasi, Vivek Gupta, Nitin Chitranshi, Petros Moustardas, Reza Ranjbaran, Stuart L. Graham (2023) Molecular Mechanisms of Glaucoma Pathogenesis with Implications to Caveolin Adaptor Protein and Caveolin-Shp2 Axis Aging and Disease Continue to DOI

2022

Eirini Apostolou, Muhammad Rizwan, Petros Moustardas, Per Sjögren, Bo Christer Bertilson, Björn Bragée, Olli Polo, Anders Rosén (2022) Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome Frontiers in Immunology, Vol. 13, Article 949787 Continue to DOI

2021

Petros Moustardas, Naomi Yamada-Fowler, Eirini Apostolou, Athanasios G. Tzioufas, Maria V Turkina, Giannis Spyrou (2021) Deregulation of the Kallikrein Protease Family in the Salivary Glands of the Sjogren's Syndrome ERdj5 Knockout Mouse Model Frontiers in Immunology, Vol. 12, Article 693911 Continue to DOI

News

COVID-19 reactivates several latent viruses – particularly in ME patients

COVID-19 reactivated viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome. The results adds to our knowledge of the causes of the disease and prospects of reaching a diagnosis.

Tags